JPH04352708A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH04352708A JPH04352708A JP8658991A JP8658991A JPH04352708A JP H04352708 A JPH04352708 A JP H04352708A JP 8658991 A JP8658991 A JP 8658991A JP 8658991 A JP8658991 A JP 8658991A JP H04352708 A JPH04352708 A JP H04352708A
- Authority
- JP
- Japan
- Prior art keywords
- kojic acid
- kojic
- cosmetic
- acid
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 21
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229960004705 kojic acid Drugs 0.000 claims abstract description 27
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims abstract description 27
- 102000019197 Superoxide Dismutase Human genes 0.000 claims abstract description 11
- 108010012715 Superoxide dismutase Proteins 0.000 claims abstract description 11
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims abstract description 9
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 abstract description 17
- 238000004040 coloring Methods 0.000 abstract description 10
- 239000006210 lotion Substances 0.000 abstract description 9
- 239000002253 acid Substances 0.000 abstract description 7
- 150000007513 acids Chemical class 0.000 abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 239000006071 cream Substances 0.000 abstract description 5
- 230000002087 whitening effect Effects 0.000 abstract description 5
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 abstract description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 2
- 108090000790 Enzymes Proteins 0.000 abstract description 2
- 125000002252 acyl group Chemical group 0.000 abstract description 2
- 125000000217 alkyl group Chemical group 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- 229940079827 sodium hydrogen sulfite Drugs 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 3
- -1 Polyoxyethylene monoisostearate Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002845 discoloration Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000001540 sodium lactate Substances 0.000 description 3
- 229940005581 sodium lactate Drugs 0.000 description 3
- 235000011088 sodium lactate Nutrition 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- URJOWNUVTORLNY-UHFFFAOYSA-N (5-hexadecanoyloxy-4-oxopyran-2-yl) hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC1=CC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=CO1 URJOWNUVTORLNY-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 241000589220 Acetobacter Species 0.000 description 1
- 101000836247 Aquifex pyrophilus Superoxide dismutase [Fe] Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、コウジ酸を安定に含有
し、熱による経時的な着色を防止した化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to cosmetics that stably contain kojic acid and prevent coloring over time due to heat.
【0002】0002
【従来の技術】最近、紫外線の有害作用が取りざたされ
るようになり、日焼けすなわちシミ、ソバカス、老化と
いう認識が広く浸透するに至った。このため、美白効果
を有する化粧料に対する女性の関心は極めて高く、安全
で、かつ美白効果の高い化粧料に対する要求が高まって
いる。BACKGROUND OF THE INVENTION Recently, the harmful effects of ultraviolet rays have become a topic of discussion, and the perception of sunburn, that is, age spots, freckles, and aging has become widespread. For this reason, women are extremely interested in cosmetics that have a whitening effect, and there is an increasing demand for cosmetics that are safe and have a high whitening effect.
【0003】そのためメラニンに関する研究も発展し、
メラニンの生成に関与するチロシナーゼの活性抑制や、
活性化メラノサイトの減少、消失等の効果を有する美白
成分やこれを含有する化粧料が開発されている。[0003] As a result, research on melanin has progressed,
Suppression of tyrosinase activity involved in melanin production,
Whitening ingredients that have the effect of reducing or eliminating activated melanocytes and cosmetics containing the same have been developed.
【0004】例えばアスペルギルス属等の菌株を培養し
て得られるコウジ酸及びその誘導体は、メラニン生成抑
制作用を有し、優れた美白効果を有することが知られて
いる(特開昭53−18739号公報,特開昭56−7
776号公報,特開昭56−79616号公報,特開昭
59−33207号公報等)。[0004] For example, kojic acid and its derivatives obtained by culturing strains of the genus Aspergillus are known to have an effect of suppressing melanin production and have an excellent whitening effect (Japanese Patent Application Laid-open No. 18739/1983). Publication, JP-A-56-7
776, JP-A-56-79616, JP-A-59-33207, etc.).
【0005】[0005]
【発明が解決しようとする課題】しかしながら、コウジ
酸類は化学反応性が極めて高く、熱や光により化学変化
を起こすことが知られている。このため、化粧料に配合
した場合、製品の貯蔵や流通過程において経時的に着色
が起こるという問題があった。化粧料の具備すべき条件
としては、有効性に優れるということは言うまでもない
が、配合成分の安定性や外観の美しさということも重要
である。[Problems to be Solved by the Invention] However, it is known that kojic acids have extremely high chemical reactivity and undergo chemical changes when exposed to heat or light. For this reason, when incorporated into cosmetics, there is a problem in that coloring occurs over time during storage and distribution of the product. It goes without saying that cosmetics must have excellent efficacy, but it is also important to have stability of the ingredients and a beautiful appearance.
【0006】そこで、キレート剤を配合して光による経
時的着色を防止する試みがなされてきたが、熱による経
時的着色を防止する有効な手段は未だ知られていない。[0006] Therefore, attempts have been made to prevent coloring over time due to light by incorporating a chelating agent, but no effective means for preventing coloration over time due to heat has yet been known.
【0007】従って、コウジ酸類を安定に配合し、経時
的着色を防止した化粧料の開発が要求されている。[0007]Therefore, there is a need for the development of cosmetics that stably contain kojic acids and that prevent discoloration over time.
【0008】[0008]
【課題を解決するための手段】かかる実情において、本
発明者らは上記課題を解決すべく鋭意研究を行なった結
果、コウジ酸類と共に、スーパーオキサイドジスムター
ゼ(SOD)及び/又は亜硫酸水素ナトリウムを化粧料
中に配合することにより、熱による経時的着色を防止し
得ることを見出し、本発明を完成した。[Means for Solving the Problems] Under these circumstances, the present inventors have conducted intensive research to solve the above problems, and as a result, we have developed a cosmetic product that uses superoxide dismutase (SOD) and/or sodium bisulfite together with kojic acids. The present invention was completed based on the discovery that coloring caused by heat over time can be prevented by blending the resin into the liquid.
【0009】すなわち本発明は、コウジ酸及び/又はそ
の誘導体と、SOD及び/又は亜硫酸水素ナトリウムと
を含有することを特徴とする化粧料を提供するものであ
る。That is, the present invention provides a cosmetic material containing kojic acid and/or a derivative thereof, and SOD and/or sodium bisulfite.
【0010】本発明に用いられるコウジ酸又はその誘導
体は、次の一般式Kojic acid or its derivative used in the present invention has the following general formula:
【0011】[0011]
【化1】[Chemical formula 1]
【0012】(式中、R1及びR2は、同一でも異なっ
てもよく、水素原子又は炭素数3〜22のアシル基もし
くはアルキル基を示す。)で表わされるものである。(In the formula, R1 and R2 may be the same or different and represent a hydrogen atom or an acyl group or alkyl group having 3 to 22 carbon atoms.)
【0013】コウジ酸は、アスペルギルス属、ペニシリ
ウム属、アセトバクター属等の微生物による発酵生成物
から抽出、精製したものでも、精製工程を省いた抽出物
のままのものでもよく、また合成によって得られたもの
でもよい。[0013] Kojic acid may be extracted and purified from a fermentation product by microorganisms such as Aspergillus, Penicillium, or Acetobacter, or it may be an extract without the purification process, or it may be obtained by synthesis. It may also be something you have.
【0014】また、コウジ酸誘導体としては、上記コウ
ジ酸から合成されるものが使用でき、例えばコウジ酸モ
ノブチレート、コウジ酸モノカプレート、コウジ酸モノ
パルミテート、コウジ酸モノステアレート、コウジ酸モ
ノシンナメート、コウジ酸モノベンゾエート等のモノエ
ステル;コウジ酸ジブチレート、コウジ酸ジパルミテー
ト、コウジ酸ジステアレート、コウジ酸ジオレエート等
のジエステルなどが挙げられる。Further, as the kojic acid derivative, those synthesized from the above-mentioned kojic acid can be used, such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, kojic acid monostearate, kojic acid monocinnamate. , monoesters such as kojic acid monobenzoate; and diesters such as kojic acid dibutyrate, kojic acid dipalmitate, kojic acid distearate, and kojic acid dioleate.
【0015】これらのコウジ酸及びその誘導体は、単独
で、又は二種以上を組み合わせて用いることができ、化
粧料全組成中に0.0001〜5.0重量%配合するの
が好ましい。These kojic acids and their derivatives can be used alone or in combination of two or more, and are preferably blended in an amount of 0.0001 to 5.0% by weight in the total composition of the cosmetic.
【0016】本発明に使用されるSODは、動物、植物
、微生物等の生体内に広く分布するスーパーオキサイド
消去酵素であり、下記反応によりスーパーオキサイドア
ニオン(O2−)の不均化反応を触媒するものである。
2O2−+2H+→H2O2+O2
SODは、活性中心となる金属によって、CuZn−S
OD、Mn−SOD及びFe−SODの三種があり、最
近では遺伝子工学的技術によっても多量に生産されるよ
うになっている。どの生物由来のものもアミノ酸数は1
51〜155であり、これが2量体又は4量体となって
活性を有する。例えばウシCuZn−SODの場合、1
原子のCuと1原子のZnを持った単量体(分子量約1
6kDa)2個から成っており、分子量は約32,00
0である。[0016] SOD used in the present invention is a superoxide scavenging enzyme that is widely distributed in living organisms such as animals, plants, and microorganisms, and catalyzes the disproportionation reaction of superoxide anion (O2-) by the following reaction. It is something. 2O2-+2H+→H2O2+O2 SOD is CuZn-S due to the metal serving as the active center.
There are three types: OD, Mn-SOD, and Fe-SOD, and recently they have been produced in large quantities using genetic engineering technology. The number of amino acids in all biological products is 1.
51 to 155, and this forms a dimer or tetramer and has activity. For example, in the case of bovine CuZn-SOD, 1
Monomer with one atom of Cu and one atom of Zn (molecular weight approximately 1
6kDa) and has a molecular weight of approximately 32,00
It is 0.
【0017】これらのSODは、単独で、又は2種以上
を組み合わせて用いることができ、コウジ酸又はその誘
導体の1重量部に対して0.00001〜1重量部配合
するのが好ましい。These SODs can be used alone or in combination of two or more, and are preferably blended in an amount of 0.00001 to 1 part by weight per 1 part by weight of kojic acid or its derivative.
【0018】また亜硫酸水素ナトリウムは、コウジ酸又
はその誘導体の1重量部に対して0.00001〜1重
量部配合するのが好ましい。[0018] Also, it is preferable that sodium bisulfite be blended in an amount of 0.00001 to 1 part by weight per 1 part by weight of kojic acid or its derivative.
【0019】本発明の化粧料のpHは、7.0以下とす
ることにより熱による着色の防止が更に効果的となるが
、化粧料の使用性・安全性を考慮すると、3.0以上と
するのが好ましい。かかるpHの調整は、クエン酸、コ
ハク酸、乳酸、dl−リンゴ酸、ピロリドンカルボン酸
等の有機酸又はこれらの塩を用いて行なうのが好ましい
。[0019] When the pH of the cosmetic composition of the present invention is set to 7.0 or less, the prevention of discoloration due to heat becomes more effective. It is preferable to do so. Such pH adjustment is preferably carried out using organic acids such as citric acid, succinic acid, lactic acid, dl-malic acid, and pyrrolidonecarboxylic acid, or salts thereof.
【0020】本発明の乳化化粧料には、前記の成分のほ
か、通常の化粧料に用いられる成分、例えば油剤、界面
活性剤、緩衝剤、水、低級アルコール、多価アルコール
、粉体、美容成分、増粘剤、防腐剤、色素、酸化防止剤
、紫外線吸収剤、香料、キレート剤等を、本発明の効果
を損なわない範囲で配合することができる。In addition to the above-mentioned ingredients, the emulsified cosmetic of the present invention contains ingredients used in ordinary cosmetics, such as oils, surfactants, buffers, water, lower alcohols, polyhydric alcohols, powders, and cosmetics. Ingredients such as thickeners, preservatives, pigments, antioxidants, ultraviolet absorbers, fragrances, chelating agents, etc. can be added within ranges that do not impair the effects of the present invention.
【0021】本発明の化粧料は、その形態には限定され
ず、例えば乳液、クリーム、パック、化粧水、ファンデ
ーション等として好適に使用することができる。The cosmetic composition of the present invention is not limited to its form, and can be suitably used as, for example, a milky lotion, a cream, a pack, a lotion, a foundation, and the like.
【0022】[0022]
【実施例】以下、実施例を挙げて更に詳細に説明するが
、本発明はこれらに限定されるものではない。[Examples] The present invention will be explained in more detail with reference to Examples, but the present invention is not limited thereto.
【0023】実施例1
下記組成の化粧水を調製し、経時的着色を観察した。
(組成)
(重量%
) 1. コウジ酸(三省製薬社製)
1.0 2. 1,3−ブ
チレングリコール
20.0 3. モノイソステアリン酸ポリオ
キシエチレン 硬化ヒマシ油(50E.O.
) 1
.0 4. 乳酸
0.
05 5. 乳酸ナトリウム
0.03 6
. 精製水
残量 7. 試験
物質
表1に示す濃度となる量(製法)
(1) No.1、4〜7を混合溶解する。
(2) No.2及び3を混合溶解する。
(3) (1)に(2)を攪拌しながら混合して化粧水
を得る。
(試験方法)各化粧水を、40℃又は室温で3ヵ月間恒
温槽中に放置し、その着色程度を400nmの吸光度を
測定することにより判定した。この結果を表1に示す。Example 1 A lotion having the following composition was prepared, and its coloring over time was observed. (composition)
(weight%
) 1. Kojic acid (manufactured by Sansei Pharmaceutical Co., Ltd.)
1.0 2. 1,3-butylene glycol
20.0 3. Polyoxyethylene monoisostearate Hydrogenated castor oil (50E.O.
) 1
.. 0 4. lactic acid
0.
05 5. sodium lactate
0.03 6
.. purified water
Remaining amount 7. test substance
Amount to achieve the concentration shown in Table 1 (manufacturing method) (1) No. Mix and dissolve 1, 4 to 7. (2) No. Mix and dissolve 2 and 3. (3) Mix (1) and (2) with stirring to obtain a lotion. (Test method) Each lotion was left in a constant temperature bath at 40° C. or room temperature for 3 months, and the degree of coloration was determined by measuring the absorbance at 400 nm. The results are shown in Table 1.
【0024】[0024]
【表1】[Table 1]
【0025】表1より、亜硫酸水素ナトリウムは高温側
、SODは低温側でより効果的であった。From Table 1, sodium bisulfite was more effective at high temperatures, and SOD was more effective at lower temperatures.
【0026】実施例2 化粧水:(処方)
(重量%
) 1. コウジ酸(三省製薬社製)
1.0 2. 1,3−ブ
チレングリコール
20.0 3. モノイソステアリン酸ポリオ
キシエチレン 硬化ヒマシ油(50E.O.
) 1
.0 4. 乳酸
0.
05 5. 乳酸ナトリウム
0.03 6
. 精製水
残量 7. 亜硫
酸水素ナトリウム
0.25(製法)
(1) No.1、4〜7を混合溶解する。
(2) No.2及び3を混合溶解する。
(3) (1)に(2)を攪拌しながら混合して化粧水
を得る。
(結果)上記の如くして得られた化粧水は、熱による経
時的な着色が改善されたものであった。Example 2 Lotion: (Formulation)
(weight%
) 1. Kojic acid (manufactured by Sansei Pharmaceutical Co., Ltd.)
1.0 2. 1,3-butylene glycol
20.0 3. Polyoxyethylene monoisostearate Hydrogenated castor oil (50E.O.
) 1
.. 0 4. lactic acid
0.
05 5. sodium lactate
0.03 6
.. purified water
Remaining amount 7. sodium bisulfite
0.25 (manufacturing method) (1) No. Mix and dissolve 1, 4 to 7. (2) No. Mix and dissolve 2 and 3. (3) Mix (1) and (2) with stirring to obtain a lotion. (Results) The lotion obtained as described above had improved coloring over time due to heat.
【0027】実施例3 クリーム:(処方)
(重量%
) 1. ポリオキシエチレン(20E.O.)セチ
ルエーテル 2.0 2. グリセリルステアレ
ート 2.
0 3. セトステアリルアルコール
1.0 4. 流動パラフ
ィン
10.0 5. マカデミアンナッツ油
10.0
6. プロピレングリコール
10.0 7. パラベン
0.1 8. 乳酸
0.05 9. 乳酸ナトリウム
0.03 10. 亜硫酸水素ナトリウム
0.0
5 11. コウジ酸(三省製薬社製)
1.0 12. 精製水
残量(製法)
(1) No.1〜5を70℃にて混合溶解する。
(2) No.6〜12を70℃にて混合溶解する。
(3) (1)に(2)を加えて乳化後冷却し、クリー
ムを得る。
(結果)上記の如くして得られたクリームは、熱による
経時的な着色が改善されたものであった。Example 3 Cream: (Formulation)
(weight%
) 1. Polyoxyethylene (20E.O.) cetyl ether 2.0 2. Glyceryl stearate 2.
0 3. Cetostearyl alcohol
1.0 4. liquid paraffin
10.0 5. macadamian nut oil
10.0
6. Propylene glycol
10.0 7. Paraben
0.1 8. lactic acid
0.05 9. sodium lactate
0.03 10. sodium bisulfite
0.0
5 11. Kojic acid (manufactured by Sansei Pharmaceutical Co., Ltd.)
1.0 12. purified water
Remaining amount (manufacturing method) (1) No. 1 to 5 are mixed and dissolved at 70°C. (2) No. 6 to 12 are mixed and dissolved at 70°C. (3) Add (2) to (1), emulsify, and then cool to obtain cream. (Results) The cream obtained as described above had improved coloring over time due to heat.
【0028】実施例4 パック:(処方)
(重量%
) 1. ポリビニルアルコール
20.0 2. エタノ
ール
10.0 3. リンゴ酸
0.1 4. リンゴ酸ナトリウム
0
.02 5. SOD
0.
0001 6. コウジ酸(三省製薬社製)
1.0 7. グリ
セリン
10.0 8. 精製水
残量(製法)
(1) No.3〜7をNo.8に混合溶解する。
(2) (1)にNo.1及び2を加えて加熱膨潤した
後冷却し、パックを得る。
(結果)上記の如くして得られたパックは、熱による経
時的な着色が改善されたものであった。Example 4 Pack: (Formulation)
(weight%
) 1. polyvinyl alcohol
20.0 2. ethanol
10.0 3. malic acid
0.1 4. sodium malate
0
.. 02 5. SOD
0.
0001 6. Kojic acid (manufactured by Sansei Pharmaceutical Co., Ltd.)
1.0 7. glycerin
10.0 8. purified water
Remaining amount (manufacturing method) (1) No. 3 to 7 as No. Mix and dissolve in 8. (2) No. in (1). 1 and 2 are added, heated and swollen, and then cooled to obtain a pack. (Results) The pack obtained as described above had improved discoloration over time due to heat.
【0029】[0029]
【発明の効果】以上のように、本発明の化粧料はコウジ
酸を安定に含有し、その経時的着色、特に熱による経時
的な着色の問題が改善されるものである。As described above, the cosmetic composition of the present invention stably contains kojic acid, and the problem of coloring over time, especially over time due to heat, can be improved.
Claims (1)
ーパーオキサイドジスムターゼ及び/又は亜硫酸水素ナ
トリウムとを含有することを特徴とする化粧料。1. A cosmetic comprising kojic acid and/or a derivative thereof, and superoxide dismutase and/or sodium bisulfite.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP08658991A JP3380261B2 (en) | 1991-04-18 | 1991-04-18 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP08658991A JP3380261B2 (en) | 1991-04-18 | 1991-04-18 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04352708A true JPH04352708A (en) | 1992-12-07 |
JP3380261B2 JP3380261B2 (en) | 2003-02-24 |
Family
ID=13891199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP08658991A Expired - Lifetime JP3380261B2 (en) | 1991-04-18 | 1991-04-18 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3380261B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07196442A (en) * | 1994-01-11 | 1995-08-01 | Sansho Seiyaku Co Ltd | External agent for skin |
US6497860B1 (en) | 1996-11-04 | 2002-12-24 | Children's Hospital Medical Center | Skin lightening compositions |
JP2005298489A (en) * | 2004-03-15 | 2005-10-27 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2010043088A (en) * | 2004-03-15 | 2010-02-25 | Kyoei Kagaku Kogyo Kk | Cosmetic product |
GB2497985A (en) * | 2011-12-28 | 2013-07-03 | Pangaea Lab Ltd | Stable kojic acid composition to lighten the skin |
-
1991
- 1991-04-18 JP JP08658991A patent/JP3380261B2/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07196442A (en) * | 1994-01-11 | 1995-08-01 | Sansho Seiyaku Co Ltd | External agent for skin |
US6497860B1 (en) | 1996-11-04 | 2002-12-24 | Children's Hospital Medical Center | Skin lightening compositions |
JP2005298489A (en) * | 2004-03-15 | 2005-10-27 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2010043088A (en) * | 2004-03-15 | 2010-02-25 | Kyoei Kagaku Kogyo Kk | Cosmetic product |
GB2497985A (en) * | 2011-12-28 | 2013-07-03 | Pangaea Lab Ltd | Stable kojic acid composition to lighten the skin |
GB2497985B (en) * | 2011-12-28 | 2014-03-12 | Pangaea Lab Ltd | A composition to stabilise kojic acid |
AU2012268879B2 (en) * | 2011-12-28 | 2015-08-06 | Medik8 Limited | A Composition to Stabilise Kojic Acid |
Also Published As
Publication number | Publication date |
---|---|
JP3380261B2 (en) | 2003-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3510482C2 (en) | Use of a hydroquinone glycoside to prevent skin irritants caused by UV absorbers in skin treatment agents | |
JP2565513B2 (en) | Topical drug for suppressing melanin production | |
JP2502318B2 (en) | Whitening cosmetics | |
JP3661706B2 (en) | Topical skin preparation | |
KR930007911B1 (en) | External preparations free of discoloration | |
JP2000095663A (en) | Agent for external use containing plant extract | |
CN1838935B (en) | Agent for eliminating singlet oxygen and composition using the same | |
JPH07126135A (en) | Skin external preparation | |
JPS5883648A (en) | Lanolin acid copper and local composition | |
JPH0812565A (en) | Skin external preparation | |
JP2822093B2 (en) | W / O / W type emulsified cosmetic | |
JPH04352708A (en) | Cosmetic | |
JPH0648935A (en) | Melamine production-inhibiting external agent | |
JPH07309739A (en) | Suppressant for fragmentation of mucopolysaccharides and cosmetic | |
KR20030005201A (en) | Skin preparations for external use | |
JPH10279421A (en) | Preparation for external use for skin | |
JP2753639B2 (en) | Cosmetics | |
JPH07149622A (en) | Beautifying and whitening preparation | |
JPS60188306A (en) | Cosmetic | |
JPH1046143A (en) | Antioxidant | |
JPH1046142A (en) | Antioxidant | |
JP2004217597A (en) | Collagen production promotor | |
JPH03127712A (en) | Agent for external application | |
JPH04120008A (en) | New beautifying cosmetic | |
JP3643167B2 (en) | Topical skin preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071213 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081213 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081213 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091213 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091213 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101213 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111213 Year of fee payment: 9 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111213 Year of fee payment: 9 |